These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 10414726)
1. Prognostic significance of angiogenesis and immunoreactivity of cathepsin D and type IV collagen in high-grade stage T1 primary bladder cancer. Ozer E; Mungan MU; Tuna B; Kazimoğlu H; Yörükoğlu K; Kirkali Z Urology; 1999 Jul; 54(1):50-5. PubMed ID: 10414726 [TBL] [Abstract][Full Text] [Related]
2. Does angiogenesis predict recurrence in superficial transitional cell carcinoma of the bladder? Sağol O; Yörükoğlu K; Sis B; Tuna B; Ozer E; Güray M; Mungan U; Kirkali Z Urology; 2001 May; 57(5):895-9. PubMed ID: 11337289 [TBL] [Abstract][Full Text] [Related]
3. An immunohistochemical and prognostic evaluation of cathepsin D expression in 105 bladder carcinomas. Dickinson AJ; Fox SB; Newcomb PV; Persad RA; Sibley GN; Harris AL J Urol; 1995 Jul; 154(1):237-41. PubMed ID: 7776437 [TBL] [Abstract][Full Text] [Related]
4. Prognostic impact of angiogenesis in nonmuscle invasive bladder cancer as defined by microvessel density after immunohistochemical staining for CD34. Ajili F; Kacem M; Tounsi H; Darouiche A; Enayfer E; Chebi M; Manai M; Boubaker S Ultrastruct Pathol; 2012 Oct; 36(5):336-42. PubMed ID: 22574784 [TBL] [Abstract][Full Text] [Related]
5. Angiogenesis in bladder cancer: relationship between microvessel density and tumor prognosis. Bochner BH; Cote RJ; Weidner N; Groshen S; Chen SC; Skinner DG; Nichols PW J Natl Cancer Inst; 1995 Nov; 87(21):1603-12. PubMed ID: 7563203 [TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of angiogenesis in superficial bladder cancer. Stavropoulos NE; Bouropoulos C; Ioachim IE; Michael M; Hastazeris K; Tsimaris I; Kalogeras D; Liamis Z; Stefanaki S; Agnantis NI Int Urol Nephrol; 2004; 36(2):163-7. PubMed ID: 15368686 [TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical studies of proliferating cell nuclear antigen and cathepsin D in transitional cell carcinoma of the urinary bladder. Iizumi T; Iiyama T; Tanaka W; Okada E; Kamiyama Y; Okano Y; Sato S; Yazaki T; Umeda T; Imamura T Urol Int; 1997; 59(2):81-7. PubMed ID: 9392054 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of vascular endothelial growth factors A, C and D as indicators of lymphangiogenesis and angiogenesis in invasive and non-invasive urothelial carcinoma bladder. Khadim MT; Ahmed SA; Khan FA; Ikram A; Shaikh SY J Pak Med Assoc; 2015 Aug; 65(8):851-6. PubMed ID: 26228330 [TBL] [Abstract][Full Text] [Related]
10. Cathepsin D in ovarian cancer: prognostic value and correlation with p53 expression and microvessel density. Lösch A; Schindl M; Kohlberger P; Lahodny J; Breitenecker G; Horvat R; Birner P Gynecol Oncol; 2004 Feb; 92(2):545-52. PubMed ID: 14766246 [TBL] [Abstract][Full Text] [Related]
11. Differential Expression of PD-L1 in High Grade T1 vs Muscle Invasive Bladder Carcinoma and its Prognostic Implications. Wankowicz SAM; Werner L; Orsola A; Novak J; Bowden M; Choueiri TK; de Torres I; Morote J; Freeman GJ; Signoretti S; Bellmunt J J Urol; 2017 Oct; 198(4):817-823. PubMed ID: 28487100 [TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of type IV collagen and laminin immunoreactivity in urothelial carcinomas of the bladder. Schapers RF; Pauwels RP; Havenith MG; Smeets AW; van den Brandt PA; Bosman FT Cancer; 1990 Dec; 66(12):2583-8. PubMed ID: 2249199 [TBL] [Abstract][Full Text] [Related]
13. Microvessel density as a prognostic marker in bladder carcinoma: correlation with tumor grade, stage and prognosis. Canoğlu A; Göğüş C; Bedük Y; Orhan D; Tulunay O; Baltaci S Int Urol Nephrol; 2004; 36(3):401-5. PubMed ID: 15783115 [TBL] [Abstract][Full Text] [Related]
14. Investigation of pericytes, hypoxia, and vascularity in bladder tumors: association with clinical outcomes. O'Keeffe MB; Devlin AH; Burns AJ; Gardiner TA; Logan ID; Hirst DG; McKeown SR Oncol Res; 2008; 17(3):93-101. PubMed ID: 18669161 [TBL] [Abstract][Full Text] [Related]
15. Association of cyclooxygenase-2 expression with prognosis of stage T1 grade 3 bladder cancer. Kim SI; Kwon SM; Kim YS; Hong SJ Urology; 2002 Nov; 60(5):816-21. PubMed ID: 12429306 [TBL] [Abstract][Full Text] [Related]
16. Recurrence, progression and success in stage Ta grade 3 bladder tumors treated with low dose bacillus Calmette-Guerin instillations. Lebret T; Bohin D; Kassardjian Z; Herve JM; Molinie V; Barre P; Lugagne PM; Botto H J Urol; 2000 Jan; 163(1):63-7. PubMed ID: 10604315 [TBL] [Abstract][Full Text] [Related]
17. Relationship among cystectomy, microvessel density and prognosis in stage T1 transitional cell carcinoma of the bladder. Dinney CP; Babkowski RC; Antelo M; Perrotte P; Liebert M; Zhang HZ; Palmer J; Veltri RW; Katz RL; Grossman HB J Urol; 1998 Oct; 160(4):1285-90. PubMed ID: 9751337 [TBL] [Abstract][Full Text] [Related]
18. EORTC Nomograms and Risk Groups for Predicting Recurrence, Progression, and Disease-specific and Overall Survival in Non-Muscle-invasive Stage Ta-T1 Urothelial Bladder Cancer Patients Treated with 1-3 Years of Maintenance Bacillus Calmette-Guérin. Cambier S; Sylvester RJ; Collette L; Gontero P; Brausi MA; van Andel G; Kirkels WJ; Silva FC; Oosterlinck W; Prescott S; Kirkali Z; Powell PH; de Reijke TM; Turkeri L; Collette S; Oddens J Eur Urol; 2016 Jan; 69(1):60-9. PubMed ID: 26210894 [TBL] [Abstract][Full Text] [Related]
19. Initial high-grade T1 urothelial cell carcinoma: feasibility and prognostic significance of lamina propria invasion microstaging (T1a/b/c) in BCG-treated and BCG-non-treated patients. Orsola A; Trias I; Raventós CX; Español I; Cecchini L; Búcar S; Salinas D; Orsola I Eur Urol; 2005 Aug; 48(2):231-8; discussion 238. PubMed ID: 15963635 [TBL] [Abstract][Full Text] [Related]
20. p53 and microvessel density in primary resection specimens of superficial bladder cancer. Reiher F; Ozer O; Pins M; Jovanovic BD; Eggener S; Campbell SC J Urol; 2002 Mar; 167(3):1469-74. PubMed ID: 11832772 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]